Sign Out
Posology: Arexvy is administered as a single dose of 0.5 mL.
The need for revaccination with a subsequent dose has not been established (see Pharmacology: Pharmacodynamics under Actions).
Paediatric population: The safety and efficacy of Arexvy in children have not been established. No data are available.
Method of administration: For intramuscular injection only, preferably in the deltoid muscle.
For instructions on reconstitution of the medicinal product before administration, see Special precautions for disposal and other handling under Cautions for Usage.
